Literature DB >> 3017397

Receptors for EGF and oestradiol and thymidinekinase activity in different histological subgroups of human mammary carcinomas.

L Skoog, A Macias, E Azavedo, J Lombardero, C Klintenberg.   

Abstract

The cellular content of receptors for epidermal growth factor (EGF) was measured in different histological subgroups of human mammary carcinomas. EGF receptors were detected in 36% of the ductal and all the medullary carcinomas. In contrast lobular and pure colloid tumours did not contain measurable amounts of the receptor. The receptor was found both among tumours with an euploid and aneuploid DNA pattern. The EGF receptor is thus found in carcinomas with a varying degree of differentiation as judged by the cellular DNA pattern. There was no correlation between the proliferative activity of the tumours as measured by thymidinekinase activity and the amount of EGF receptors in the tumour. Tumours with detectable EGF receptor often had low levels of oestrogen receptor. This finding could only partly be explained by the menstrual status of the patients.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3017397      PMCID: PMC2001521          DOI: 10.1038/bjc.1986.173

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  20 in total

1.  Preparation of iodine-131 labelled human growth hormone of high specific activity.

Authors:  W M HUNTER; F C GREENWOOD
Journal:  Nature       Date:  1962-05-05       Impact factor: 49.962

2.  A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid.

Authors:  K BURTON
Journal:  Biochem J       Date:  1956-02       Impact factor: 3.857

3.  Selective reduction in receptors for epidermal growth factor-urogastrone in chemically transformed tumorigenic Syrian hamster embryo fibroblasts.

Authors:  M D Hollenberg; J C Barrett; P O Ts'o; P Berhanu
Journal:  Cancer Res       Date:  1979-10       Impact factor: 12.701

4.  Colloid carcinoma of the breast.

Authors:  S G Silverberg; S Kay; A R Chitale; S H Levitt
Journal:  Am J Clin Pathol       Date:  1971-03       Impact factor: 2.493

5.  Epidermal growth factor and a new derivative. Rapid isolation procedures and biological and chemical characterization.

Authors:  C R Savage; S Cohen
Journal:  J Biol Chem       Date:  1972-12-10       Impact factor: 5.157

6.  Cytosol estradiol receptor in human mammary carcinoma: an assay based on isoelectric focusing in polyacrylamide gel.

Authors:  O Wrange; B Nordenskjöld; J A Gustafsson
Journal:  Anal Biochem       Date:  1978-04       Impact factor: 3.365

7.  An evaluation of Feulgen-acriflavine-SO2 and Hoechst 33258 for DNA cytofluorometry in tumour pathology.

Authors:  K Bjelkenkrantz
Journal:  Histochemistry       Date:  1983

8.  Epidermal growth factor binding by breast tumor biopsies and relationship to estrogen receptor and progestin receptor levels.

Authors:  S L Fitzpatrick; J Brightwell; J L Wittliff; G H Barrows; G S Schultz
Journal:  Cancer Res       Date:  1984-08       Impact factor: 12.701

9.  Receptors for retinoic acid and retinol in human mammary carcinomas.

Authors:  L Skoog; S Humla; C Klintenberg; M Pasqual; A Wallgren
Journal:  Eur J Cancer Clin Oncol       Date:  1985-08

10.  Expression of epidermal growth factor receptors in human brain tumors.

Authors:  T A Libermann; N Razon; A D Bartal; Y Yarden; J Schlessinger; H Soreq
Journal:  Cancer Res       Date:  1984-02       Impact factor: 12.701

View more
  7 in total

1.  Effects of growth factors on proliferation on basal and luminal cells in human breast epithelial explants in serum-free culture.

Authors:  N P Perusinghe; P Monaghan; M J O'Hare; S Ashley; B A Gusterson
Journal:  In Vitro Cell Dev Biol       Date:  1992-02

2.  Epidermal growth factor receptor assay: validation of a single point method and application to breast cancer.

Authors:  J L Formento; M Francoual; P Formento; M C Etienne; J L Fischel; M Namer; M Frenay; E François; G Milano
Journal:  Breast Cancer Res Treat       Date:  1991 Jan-Feb       Impact factor: 4.872

3.  Expression of epidermal growth factor receptor in benign and malignant primary tumours of the breast.

Authors:  P Möller; G Mechtersheimer; M Kaufmann; G Moldenhauer; F Momburg; T Mattfeldt; H F Otto
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

4.  The prognostic significance of epidermal growth factor receptor expression in breast cancer.

Authors:  M Noguchi; Y Mizukami; K Kinoshita; M Earashi; M Thomas; I Miyazaki
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

5.  Prognostic value of epidermal growth factor receptor in node-positive breast cancer.

Authors:  M Grimaux; S Romain; Y Remvikos; P M Martin; H Magdelénat
Journal:  Breast Cancer Res Treat       Date:  1989-10       Impact factor: 4.872

6.  Epidermal growth factor receptor and oestrogen receptors in the non-malignant part of the cancerous breast.

Authors:  S Barker; C Panahy; J R Puddefoot; A W Goode; G P Vinson
Journal:  Br J Cancer       Date:  1989-11       Impact factor: 7.640

7.  Epidermal growth factor receptor status of histological sub-types of breast cancer.

Authors:  J R Sainsbury; S Nicholson; B Angus; J R Farndon; A J Malcolm; A L Harris
Journal:  Br J Cancer       Date:  1988-10       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.